{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-009035","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.107792+00:00","generated_at":"2026-05-25T12:58:09.020119+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Nephros CFO Krandel gets two stock options, bonus target raised to 30%","bullets":["Amendment to CFO Judith Krandel's letter agreement grants options for 54,359 and 58,961 shares under 2024 Equity Incentive Plan.","First option vests 25% on first anniversary, then quarterly over 3 years; second vests upon closing a strategic transaction adding ≥$4M annual revenue.","Annual performance bonus target increased to 30% of base salary; options accelerate upon termination without cause.","Grant date is 3rd business day after filing 2024 10-K; exercise price equals closing price on grant date."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-009035","json":"https://secwatch.observer/filing/0001493152-25-009035.json","markdown":"https://secwatch.observer/filing/0001493152-25-009035.md","text":"https://secwatch.observer/filing/0001493152-25-009035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315225009035/0001493152-25-009035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315225009035/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T12:58:09.020119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}